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Background: Drawing conclusions from systematic reviews of test accuracy studies without considering the
methodological quality (risk of bias) of included studies may lead to unwarranted optimism about the value of the
test(s) under study. We sought to identify to what extent the results of quality assessment of included studies are
incorporated in the conclusions of diagnostic accuracy reviews.
Methods: We searched MEDLINE and EMBASE for test accuracy reviews published between May and September
2012. We examined the abstracts and main texts of these reviews to see whether and how the results of quality
assessment were linked to the accuracy estimates when drawing conclusions.
Results: We included 65 reviews of which 53 contained a meta-analysis. Sixty articles (92%) had formally assessed
the methodological quality of included studies, most often using the original QUADAS tool (n = 44, 68%). Quality
assessment was mentioned in 28 abstracts (43%); with a majority (n = 21) mentioning it in the methods section.
In only 5 abstracts (8%) were results of quality assessment incorporated in the conclusions. Thirteen reviews (20%)
presented results of quality assessment in the main text only, without further discussion. Forty-seven reviews (72%)
discussed results of quality assessment; the most frequent form was as limitations in assessing quality (n = 28). Only
6 reviews (9%) further linked the results of quality assessment to their conclusions, 3 of which did not conduct a
meta-analysis due to limitations in the quality of included studies. In the reviews with a meta-analysis, 19 (36%)
incorporated quality in the analysis. Eight reported significant effects of quality on the pooled estimates; in none
of them these effects were factored in the conclusions.
Conclusion: While almost all recent diagnostic accuracy reviews evaluate the quality of included studies, very few
consider results of quality assessment when drawing conclusions. The practice of reporting systematic reviews of
test accuracy should improve if readers not only want to be informed about the limitations in the available
evidence, but also on the associated implications for the performance of the evaluated tests.
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Systematic reviews of diagnostic test accuracy form a
fundamental part of evidence-based practice [1,2]. An
essential part of a systematic review is the evaluation of
the risk of bias [3] also referred to as assessment of
methodological quality [4]. Limitations in the design and
conduct of the study may lead to overestimation of the
accuracy of the test under study [5,6]. This is of concern,
because tests introduced in practice based on weak evi-
dence may lead to misdiagnosis, improper management
of patients and, subsequently, poor health outcomes [7-9].
Such limited evidence could also lead to unnecessary
testing and avoidable health care costs [7].
The Quality Assessment for Diagnostic Accuracy Studies
tool (QUADAS) has been developed and introduced to
evaluate the methodological quality of studies included in
systematic reviews of test accuracy [10]. A revised version,
QUADAS-2, was introduced in 2011. The revised instru-
ment considers methodological quality in terms of risk of
bias and concerns regarding the applicability of findings
to the research question. It does so in four key domains:
patient selection, index test, reference test, and patient
flow [11]. The QUADAS-2 tool is recommended by the
U.K National Institute for Health and Clinical Excellence,
the Cochrane Collaboration, and the U.S. Agency for
Healthcare Research and Quality.
The use of QUADAS in test accuracy reviews to assess
the methodological quality of included primary studies
is increasing. Willis and Quigley reported that 40% of
diagnostic reviews published between 2006 and 2008 used
the QUADAS tool [12], while Dahabreh and colleagues
reported that, in 2004, about 2% of diagnostic reviews
used QUADAS, while 44% did so in 2009 [13].
Simply assessing quality without interpreting and using
the results to draw conclusions is not sufficient in evidence
synthesis. The results from quality assessment should be
used to make inferences about the validity of the results.
The challenge of incorporating quality assessments of
the included studies into the overall findings of a review
is well known in intervention reviews. Moja and colleagues
[14] reported that just about half of the 965 reviews
they examined had incorporated the results of quality
assessment in their analysis and interpretation of the
results of their studies. A similar study done almost
10 years later by Hopewell and colleagues [15] reported
that only 41% of the 200 reviews they examined incorpo-
rated the risk of bias assessment into the interpretation of
their conclusions. The challenge of incorporating results
of quality assessment in the conclusions may also be
present in diagnostic accuracy reviews.
Readers, who usually have limited or basic knowledge of
the methodological process involved in diagnostic reviews,
often focus exclusively on the conclusion sections of a
review when arriving at a judgment about a test’sperformance [16]. In this regard, drawing conclusions
without considering the risk of bias in included studies
may lead to unwarranted optimism about the value of
the test(s) under study. We sought to identify to what
extent – and, if so, how – quality assessment is incorpo-
rated in the conclusions of diagnostic accuracy reviews.
Methods
This study was part of a larger meta-epidemiological
study to examine the methodology used in recent test
accuracy reviews. Since diffusion of methods takes time,
we focused on recently published reviews. On 12th
September 2012, we identified a convenience sample of
test accuracy reviews indexed in the databases MEDLINE
and EMBASE between 1st May and 11th September 2012
using the search strategy available in Additional file 1.
Eligible were reviews with a systematic search and
methodology in appraising and summarising studies that
evaluated a medical test against a reference standard.
These reviews could present summary accuracy measures
generated in a meta-analysis or present a range of accur-
acy measures without a summary measure. We included
reviews published in English and which evaluated human
studies dealing with patient data (as opposed to specimen
data). We excluded individual patient data reviews and
reviews evaluating the accuracy of prognostic tests in
predicting future events. The methodology for evaluating
quality in reviews of prognostic tests is less well developed
than that for diagnostic tests.
The data extraction form was pilot tested by performing
double data extraction on a third of the articles (by E.O.,
W.E., C.N., J.G., L.H., and M.L.). Discrepancies were
discussed and unclear questions on the form were made
more specific. Data extraction was then performed by one
researcher (by E.O., W.E., C.N., and M.L.) using the stan-
dardized form and checked by another researcher (by E.
O., W.E., C.N., and M.L.). Disagreements were resolved
through discussion and when necessary by including a
third reviewer (P.B.).
As conclusions are influenced largely by the methods
used and the results produced in a review, we first ex-
amined every included review to check if methodological
quality of included studies had been assessed using the
recommended tool, QUADAS or QUADAS-2 [10,11], or
any other tool that the authors specified as a system to
assess risk of bias.
We examined the abstracts to check if methodological
quality was mentioned in any of the sections (background,
methods, results and conclusions). Abstracts are the most
commonly read part of articles and readers often rely
on abstracts to give them a snapshot of the content of
reviews; where full texts cannot be accessed, judgments
of a test’s performance may be made on abstracts alone
[17-19].
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if the methodological quality of included studies was
assessed, which tool had been used to assess quality,
how results of quality assessments were presented, if
the quality of studies had influenced the decision to
perform a meta-analysis, if and how an assessment of
quality was incorporated into the analysis, and if and how
the results of quality assessment were discussed and even-
tually used in drawing conclusions about the test.
We regarded quality as being incorporated into the
conclusions of the review when results of quality assess-
ment of the included studies, or limitations surrounding
quality assessment, were considered together with the
accuracy estimates of the diagnostic tests in drawing
conclusions about the performance of the test(s) under
evaluation. We distinguished between drawing conclu-
sions about test performance and making recommenda-
tions for future research. Conclusions of test performance
are usually based solely on the results of the review and
could be used as guidance for clinical practice, whereas
recommendations for research are generally made after
considering additional information not necessarily investi-
gated in the review itself.Results
Search results
The initial search identified 1,273 articles. We excluded
1,184 articles after screening titles and abstracts, and
had to exclude 24 more articles after reading the full
text. Sixty-five reviews were eventually included in this
study on quality assessment. Of these reviews, 53 con-
tained a meta-analysis (see Figure 1).Figure 1 Flow chart of study inclusion.Characteristics of included reviews
Details of the study characteristics are outlined in Table 1.
In summary, this sample of 65 reviews included one
Cochrane review and 64 reviews published in other
peer-reviewed journals. The median impact factor of
the journals in which the included reviews were pub-
lished in was 3.1 [Interquartile range, 2.4 to 4.1]. Of all
the tests evaluated in the included reviews, imaging
tests formed the largest group (n = 36, 55%).
Instruments used to assess methodological quality
Of the included reviews, 60 (92%) had formally assessed
the methodological quality of included studies. Most
reviews had used QUADAS to assess the quality of in-
cluded studies (n = 44) and most presented their results
as tables of individual quality items (n = 31). Details of
this assessment are outlined in Table 1.
Incorporation of assessments of quality in the review
a. Abstract
Table 2 summarizes the approaches used to mention
quality in the abstract of the review with examples.
Quality assessment was only mentioned in 28 abstracts
(43%); a majority of these referred to it in the methods
section (n = 21). Only 5 reviews [20-24] linked results
of quality assessment to accuracy estimates in the conclu-
sion of the abstract. Three of these had not performed
a meta-analysis [22-24], due to the poor quality of in-
cluded studies.
b. Main text
Table 1 Characteristics of included reviews
Characteristic Number (%)
N = 65
Number of primary studies in reviews,
median [IQ range]
16 [10–24]
Journal impact factor, median [IQ range] 3.1 [2.4-4.1]
Type of test evaluated
Imaging test 36 (55)
Laboratory test 17 (26)
Other 12 (18)
Publication
Cochrane library 1 (1)
Other peer reviewed journals 64 (99)
Quality assessment tools
No quality assessment 5 (8)
QUADAS 44 (68)
QUADAS-2 1 (1)
STARD 3 (5)
Both QUADAS and STARD 4 (6)
Quality assessment
of reliability studies
1 (1)
Other checklists of
quality criteria
6 (9)
Unclear 1 (1)
Presentation of
quality results*
Table of individual quality items 31 (48)
Summary score 18 (28)
Summary graph 12 (18)
Narrative explanation 7 (11)
Other 5 (8)
*One review could have one or more ways of presenting results.
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used to incorporate quality in the main text of the review.
The detailed breakdown of how quality was incorporated
in the analysis, discussion and eventually to the conclu-
sions in the main text of the review is presented below.
Incorporation in the analysis
Twelve of the included reviews did not contain a meta-
analysis. Four reviews [22-24,31] cited the poor quality
of the identified studies as a reason for not conducting a
meta-analysis, three [22-24] of which further factored the
poor quality of studies in their conclusion. Other reasons
for not conducting a meta-analysis were heterogeneity
in test executions or study populations (n = 5) and not
meeting inclusion criteria (n = 1); 2 reviews did not give
an explanation.Among the reviews with a meta-analysis (n = 53), nine-
teen (36%) incorporated quality in the analysis. Quality
was incorporated in the analysis using meta-regression
(n = 6), sensitivity analysis (n = 4), subgroup analysis (n = 2),
both meta-regression and subgroup analysis (n = 2) or
through unspecified methods, (n = 5). Eight found signifi-
cant effects of quality on accuracy; in none of them these
effects were factored in the conclusions.
Incorporation in the discussion
Thirteen reviews (20%) only presented results of quality
assessment, without further discussion; most of these
(n = 12) contained a meta-analysis. In total, 47 reviews
(72%) discussed the results of quality assessment but only
6 (9%) further linked these results to their conclusions.
Ten reviews without a meta-analysis discussed their
results but only four [21-24] linked these results to their
conclusions. Quality was discussed as a study limitation
(n = 7), as a strength of the review (n = 2) and as potentially
influencing the accuracy estimates (n = 1).
For the reviews with a meta-analysis, the results of
the quality assessment were discussed 35 times in the
discussion section, and twice in the results section. In
the discussion section, quality was discussed as a study
limitation (n = 21), as a strength of the study (n = 7), as a
summary of results of the analysis (n = 11), and as poten-
tially influencing the summary estimates of the review
(n = 4). Eight studies discussed quality in more than
one way. In the results section, quality was discussed as
potentially influencing the summary estimates of the
review (n = 1) and as strength of the review (n = 1).
Twenty of the reviews that did not incorporate quality
in their analysis (n = 30) discussed their results of quality
assessment. They did so mostly as limitations in assessing
the quality of included studies (n = 14, 70%).
Incorporation in conclusions
In total, only 6 reviews (9%) incorporated the results of
quality assessment in their conclusions in the main text
of the review [20-24,32]. Most of which (n = 4) were
reviews without a meta-analysis [21-24]. Three reviews
cited poor quality as a reason for not conducting a
meta-analysis [22-24].
Of these 6 reviews that incorporated quality in the con-
clusions, 3 were published in a journal with an impact fac-
tor above the median impact factor (3.1) of the included
reviews. In addition, 2 reviews were imaging studies and 4
reviews evaluated tests belonging to the category ‘other’.
For the reviews with a meta-analysis, one acknowledged
the limitations in assessing the quality of included studies,
[32] and one other considered the potential effect of
the quality item ‘verification bias’ on the test’s accuracy
estimates [20]. These reviews did not highlight the
quality of included studies (high or low quality) in the
Table 2 Incorporation of quality assessment in abstracts of diagnostic reviews
Approach Overall quality of
included studies
Number
N = 65
Example
Quality mentioned
in abstract
28 (43%)a
Quality in methods 21 (32%) The quality of the studies was assessed using the guidelines published
by the QUADAS (quality assessment for studies of diagnostic accuracy,
maximum score 14) [25].
Quality in results 12 (19%) “The sensitivity analysis of 10 high quality studies (a score of > =4) showed
a pooled sensitivity of 94% and pooled specificity of 0.95” [26]
“The quality of the included studies was poor to mediocre” [27].
Quality results considered
in conclusion
5 (8%) α“The observed high sensitivity of the punch biopsy derived from all studies
is probably the result of verification bias” [20].
β“The quality of the studies investigating these tests is too low to provide a
conclusive recommendation for the clinician” [23].
aQuality was mentioned in one or more sections in the abstract.
α Example of conclusion in a review with a meta-analysis.
β Example of conclusion in a review without a meta-analysis.
Ochodo et al. BMC Medical Research Methodology 2014, 14:33 Page 5 of 8
http://www.biomedcentral.com/1471-2288/14/33main text and had not performed any statistical analysis
to investigate the effect of quality differences on pooled
estimates.
Of these two reviews, one also incorporated results of
quality assessment in the conclusion in the abstract [20].Table 3 Incorporation of quality assessment in main text of d
Approach Overall quality of
included studies
Quality mentioned in the main text
Results of quality assessment reported, no mention in
discussion or conclusion
Results of quality assessment reported and discussed,
but quality not linked to conclusion
Results of quality assessment reported and discussed,
and conclusions regarding test accuracy linked to
results of quality assessment
Results of quality assessment reported and discussed,
and recommendations based on general unspecified
quality items
bQuality was mentioned in one or more sections in the main text.
α Example of conclusion in a review with a meta-analysis.
β Example of conclusion in a review without a meta-analysis.The other review [32] encouraged authors in the conclu-
sion of the main text to be cautious when interpreting
the results of the review, because of the methodological
limitations, but did not highlight this limitation in the
conclusion of the abstract. An abstract that presentsiagnostic reviews
Number
N = 65
Example
60 (92%)b
13 (20%) Results presented as table of individual QUADAS items.
No further discussion or interpretation of results [28].
41 (63%) Assessed quality using criteria of internal and external
validity. Overall quality clearly not stated.
Discussion as limitation only: “Fourth, the variability in the
quality of the primary studies may introduce important
limitations for the interpretation of this review study”.
Conclusion: “Based on the results of this systematic review,
F-18 FDG PET (PET/CT) was useful in ruling in extrahepatic
metastases of HCC and valuable for ruling out the recurrent
HCC” [29].
6 (9%) α“ In conclusion, the observed high sensitivity and low
specificity of the colposcopy-directed punch biopsy for high
grade CIN might be a result of verification bias. The sensitivity
looks high but is probably a spurious finding caused by the
fact that most studies restricted excision mainly to women
with a positive punch biopsy” [20].
β“ There exists a wide range of physical diagnostic tests for
FAI and/or labral pathology and little information on the
diagnostic accuracy and validity. The methodological quality
of the diagnostic accuracy studies is moderate to poor ” [23].
12 (18%) Assessed quality with Original QUADAS. Only included high
quality studies based on a summary score (>9/14) “In conclusion,
T2WI combined with DWI is superior to T2WI alone in the
detection of prostate cancer. High-quality prospective studies
regarding the combination of T2WI plus DWI in detecting
prostate carcinoma still need to be conducted” [30].
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may lead to overinterpretation of the test’s accuracy
results [33].
Twelve reviews made recommendations about the test
in the main text, based on general unspecified quality
items not linked to the results of quality assessment, and
using phrases such as ‘high quality studies are needed’
or ‘large prospective studies are needed’. These were all
reviews with a meta-analysis.
Discussion
In a sample of 65 recently published diagnostic accuracy
reviews of which 53 contained a meta-analysis, we found
that almost all (92%) had assessed the methodological
quality of included studies. Yet only 6 reviews (9%) con-
sidered results of quality assessment when drawing con-
clusions about the test’s performance. Three of these
had decided not to perform a meta-analysis because of
limitations in quality of the available evidence.
Whiting and colleagues [34] have previously reviewed
existing quality assessment tools for diagnostic accuracy
studies, two years after the introduction of the original
QUADAS tool. They examined to what extent quality had
been assessed and incorporated in diagnostic systematic
reviews. Just about half of the 114 systematic reviews
examined had assessed the methodological quality of
included studies; 91 different quality assessment tools
were identified. In contrast, only 5 different quality
assessment tools could be identified in our study, with
QUADAS being used in about 8 in 10 reviews assessed.
This reinforces the existing evidence on the rapid up-
take of QUADAS [12,13].
Whiting and colleagues observed that 11 reviews (10%)
used study quality as a basis for recommendations for fu-
ture research. Yet it was unclear if these recommendations
were based on the quality as documented in the reviews.
Recommendations for future research can also be based
on aspects not necessarily investigated in the review. Our
study showed that twelve reviews made recommendations
about the test based on general unspecified quality items
not linked to the results of quality assessment, using
rather general phrases, such as ‘high quality studies are
needed’ or ‘large prospective studies are needed’.
The specific reasons for not considering the assessments
of quality of included studies in the overall findings of
reviews are unclear. The absence of quality considerations
could be partly explained by the parallel absence of clear
recommendations on how to do so: guidance on how to
incorporate quality into the conclusions of a review is
scarce and vague.
Key guidance papers on reporting and evaluating system-
atic reviews, such as the Cochrane handbook [3,4,35], the
statements on preferred reporting items for systematic re-
views and meta-analyses (PRISMA) [36], on the assessmentof multiple systematic reviews (AMSTAR) [37], and on
the grading of recommendations assessment, development
and evaluation (GRADE) [38,39] recommend that the
methodological quality of included studies is discussed
and factored into the overall findings of the review, but all
of these fall more or less short on clearly explaining how
to do so.
For instance, the Cochrane handbook for reviews of diag-
nostic accuracy studies [4,35] recommends that quality is
assessed, included in the analysis, and used to generate rec-
ommendations for future research. It does not explicitly
state how to discuss the results and incorporate the findings
into the conclusions. The PRISMA guideline [36] is explicit
in recommending that authors present the results of the
risk of bias assessment and highlight, in the discussion
section, any limitations encountered during risk of bias
assessment. About the conclusion section, the recommen-
dation in PRISMA is more vague; it advises authors to
‘provide a general interpretation of the results in the con-
text of other evidence, and implications for future re-
search’. AMSTAR [37] is a scoring system for evaluating
the quality of a systematic review, rather than that of the
studies included in such a review. One item it recom-
mends, as a measure of the quality of a review, is whether
the review used the quality of included studies in formu-
lating conclusions (Item 8). GRADE [38,39] provides a
framework for making evidence based recommendations
by rating the quality of the evidence and grading the
strength of recommendations. In this process risk of bias
assessment is a key component. The strength of GRADE
lies in providing guidance on how to make recommenda-
tions; it does not stipulate how risk of bias assessment can
be incorporated in evidence synthesis.
Another aspect to be held responsible for the absence
of quality considerations in the conclusions of systematic
reviews may be the multidimensional nature of evalua-
tions of risk of bias. Since there are multiple quality or
risk of bias items to consider, review authors may find
it difficult to select the most important quality items to
assess, analyze, discuss and draw conclusions from. Some
authors use a summary score, a quantitative estimate of
quality items evaluated. However, the use of such simple
summary scores is discouraged because they fail to con-
sider differences in importance of quality items [40,41].
Poor reporting of relevant items in primary diagnostic
accuracy studies, as stipulated by the Standards for Re-
porting of Diagnostic Accuracy initiative (STARD) [7],
limits the assessments of quality of these studies. Authors
may find it challenging to draw conclusions about the
quality of the included studies and their impact on the test
accuracy estimates when their assessments of quality or
risk of bias are unclear. Many authors of reviews in our
study discussed the challenges in assessing the quality of
included studies as a review limitation.
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DAS-2 was recently introduced - just one year before the
time of our search - and that uptake of novel methods
takes time, we did not expect to find many articles utilizing
the new version. This limited our evaluation of how results
using QUADAS-2 are incorporated into the conclusions.
Nonetheless, we anticipate that drawing conclusions from
the multiple domains of risk of bias recommended by
QUADAS-2 will still be challenging.
Although most reviews in our study did not consider
quality in drawing conclusions, the ones that did show
that it is possible to consider the strength of the evidence
in making statements about a test’s performance based
on a systematic review of test accuracy studies. If there
is no quality evidence, one can refrain from meta-analysis,
and make no firm statements about test performance. Al-
ternatively, one can explicitly qualify the results from a
meta-analysis of poor quality studies as evidence with
limited credibility. If there are studies with and studies
without deficiencies, one can limit the analysis to high
quality studies, and add explicit statements to that extent
to the conclusions. If there are studies with high risk of
bias and studies at low risk, one can explore the effects
of this variability on the summary estimates. If there
are systematic effects, one could and should factor this
finding into the conclusions. The dominant practice seems
the worst possible scenario: to evaluate the quality of
included studies without considering the findings from
that exercise in drawing conclusions.
Guidance is needed in assisting authors to incorporate
results of quality assessment in the conclusions. Such
guidance should come from concerted actions of meth-
odologists. It could be presented in the form of simple
and practical online tutorials or tutorials published in
scientific journals. Such tutorials could guide authors
with examples on how to draw conclusions, especially in
light of challenges such as the multiple domains of risk
of bias recommended by QUADAS-2, when quality of
included studies has no statistical effect on the pooled
accuracy estimates, or when the risk of bias assessment
is hampered by poor reporting of included studies, or
when poor quality of studies precludes a meta-analysis.
Conclusion
We found it disturbing that quality of the included evi-
dence was evaluated in almost all diagnostic reviews, but
that almost no authors had incorporated the results of
quality assessment in the conclusions of their reviews. The
practice of reporting systematic reviews of test accuracy
should improve if readers not only want to be informed
about the limitations in the available evidence, but also on
the associated implications for the performance of the
evaluated tests in clinical practice. Reviewers and readers
of test accuracy reviews need to check that the results orlimitations of quality assessment are incorporated in the
abstract and conclusion of the review. Simply relying on
the review results, without considering the quality of the
underlying research, could lead to the uptake of poorly
performing tests in practice and, consequently, to subopti-
mal patient management.Additional file
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